Cargando…
No Difference in Overall Survival and Non-Breast Cancer Deaths after Partial Breast Radiotherapy Compared to Whole Breast Radiotherapy—A Meta-Analysis of Randomized Trials
Purpose/objective: Adjuvant radiotherapy after breast conserving surgery is the standard approach in early stage breast cancer. However, the extent of breast tissue that has to be targeted with radiation has not been determined yet. Traditionally, the whole breast was covered by two opposing tangent...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464494/ https://www.ncbi.nlm.nih.gov/pubmed/32824414 http://dx.doi.org/10.3390/cancers12082309 |
_version_ | 1783577378491990016 |
---|---|
author | Haussmann, Jan Budach, Wilfried Corradini, Stefanie Krug, David Tamaskovics, Balint Bölke, Edwin Djiepmo-Njanang, Freddy-Joel Simiantonakis, Ioannis Kammers, Kai Matuschek, Christiane |
author_facet | Haussmann, Jan Budach, Wilfried Corradini, Stefanie Krug, David Tamaskovics, Balint Bölke, Edwin Djiepmo-Njanang, Freddy-Joel Simiantonakis, Ioannis Kammers, Kai Matuschek, Christiane |
author_sort | Haussmann, Jan |
collection | PubMed |
description | Purpose/objective: Adjuvant radiotherapy after breast conserving surgery is the standard approach in early stage breast cancer. However, the extent of breast tissue that has to be targeted with radiation has not been determined yet. Traditionally, the whole breast was covered by two opposing tangential beams. Several randomized trials have tested partial breast irradiation (PBI) compared to whole breast irradiation (WBI) using different radiation techniques. There is evidence from randomized trials that PBI might result in lower mortality rates compared to WBI. We aimed to reassess this question using current data from randomized trials. Material/methods: We performed a systematic literature review searching for randomized trials comparing WBI and PBI in early stage breast cancer with publication dates after 2009. The meta-analysis was performed using the published event rates and the effect sizes for overall survival (OS), breast cancer-specific survival (BCSS), and non-breast cancer death (NBCD) as investigated endpoints. Analysis of subgroups using different radiation techniques was intended. We used hazard ratios (HR) and risk differences (RD) to estimate pooled effect sizes. Statistical analysis was performed using the inverse variance heterogeneity model. Results: We identified eleven studies randomizing between PBI and WBI. We did not find significant differences in OS (n = 14,070; HR = 1.02; CI-95%: 0.89–1.16; p = 0.810, and n = 15,203; RD = −0.001; CI-95%: −0.008–0.006; p = 0.785) and BCSS (n = 15,203; RD = 0.001; CI-95%: −0.002–0.005; p = 0.463). PBI also did not result in a significant decrease of NBCD (n = 15,203; RD = −0.003; CI-95%: −0.010–0.003; p = 0.349). A subgroup analysis by radiation technique also did not point to any detectable differences. Conclusion: In contrast to a previous assessment of mortality, we could not find a detrimental effect of WBI on OS or NBCD. A longer follow-up might be necessary to fully assess the long-term mortality effects of PBI compared to WBI. |
format | Online Article Text |
id | pubmed-7464494 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74644942020-09-04 No Difference in Overall Survival and Non-Breast Cancer Deaths after Partial Breast Radiotherapy Compared to Whole Breast Radiotherapy—A Meta-Analysis of Randomized Trials Haussmann, Jan Budach, Wilfried Corradini, Stefanie Krug, David Tamaskovics, Balint Bölke, Edwin Djiepmo-Njanang, Freddy-Joel Simiantonakis, Ioannis Kammers, Kai Matuschek, Christiane Cancers (Basel) Article Purpose/objective: Adjuvant radiotherapy after breast conserving surgery is the standard approach in early stage breast cancer. However, the extent of breast tissue that has to be targeted with radiation has not been determined yet. Traditionally, the whole breast was covered by two opposing tangential beams. Several randomized trials have tested partial breast irradiation (PBI) compared to whole breast irradiation (WBI) using different radiation techniques. There is evidence from randomized trials that PBI might result in lower mortality rates compared to WBI. We aimed to reassess this question using current data from randomized trials. Material/methods: We performed a systematic literature review searching for randomized trials comparing WBI and PBI in early stage breast cancer with publication dates after 2009. The meta-analysis was performed using the published event rates and the effect sizes for overall survival (OS), breast cancer-specific survival (BCSS), and non-breast cancer death (NBCD) as investigated endpoints. Analysis of subgroups using different radiation techniques was intended. We used hazard ratios (HR) and risk differences (RD) to estimate pooled effect sizes. Statistical analysis was performed using the inverse variance heterogeneity model. Results: We identified eleven studies randomizing between PBI and WBI. We did not find significant differences in OS (n = 14,070; HR = 1.02; CI-95%: 0.89–1.16; p = 0.810, and n = 15,203; RD = −0.001; CI-95%: −0.008–0.006; p = 0.785) and BCSS (n = 15,203; RD = 0.001; CI-95%: −0.002–0.005; p = 0.463). PBI also did not result in a significant decrease of NBCD (n = 15,203; RD = −0.003; CI-95%: −0.010–0.003; p = 0.349). A subgroup analysis by radiation technique also did not point to any detectable differences. Conclusion: In contrast to a previous assessment of mortality, we could not find a detrimental effect of WBI on OS or NBCD. A longer follow-up might be necessary to fully assess the long-term mortality effects of PBI compared to WBI. MDPI 2020-08-17 /pmc/articles/PMC7464494/ /pubmed/32824414 http://dx.doi.org/10.3390/cancers12082309 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Haussmann, Jan Budach, Wilfried Corradini, Stefanie Krug, David Tamaskovics, Balint Bölke, Edwin Djiepmo-Njanang, Freddy-Joel Simiantonakis, Ioannis Kammers, Kai Matuschek, Christiane No Difference in Overall Survival and Non-Breast Cancer Deaths after Partial Breast Radiotherapy Compared to Whole Breast Radiotherapy—A Meta-Analysis of Randomized Trials |
title | No Difference in Overall Survival and Non-Breast Cancer Deaths after Partial Breast Radiotherapy Compared to Whole Breast Radiotherapy—A Meta-Analysis of Randomized Trials |
title_full | No Difference in Overall Survival and Non-Breast Cancer Deaths after Partial Breast Radiotherapy Compared to Whole Breast Radiotherapy—A Meta-Analysis of Randomized Trials |
title_fullStr | No Difference in Overall Survival and Non-Breast Cancer Deaths after Partial Breast Radiotherapy Compared to Whole Breast Radiotherapy—A Meta-Analysis of Randomized Trials |
title_full_unstemmed | No Difference in Overall Survival and Non-Breast Cancer Deaths after Partial Breast Radiotherapy Compared to Whole Breast Radiotherapy—A Meta-Analysis of Randomized Trials |
title_short | No Difference in Overall Survival and Non-Breast Cancer Deaths after Partial Breast Radiotherapy Compared to Whole Breast Radiotherapy—A Meta-Analysis of Randomized Trials |
title_sort | no difference in overall survival and non-breast cancer deaths after partial breast radiotherapy compared to whole breast radiotherapy—a meta-analysis of randomized trials |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464494/ https://www.ncbi.nlm.nih.gov/pubmed/32824414 http://dx.doi.org/10.3390/cancers12082309 |
work_keys_str_mv | AT haussmannjan nodifferenceinoverallsurvivalandnonbreastcancerdeathsafterpartialbreastradiotherapycomparedtowholebreastradiotherapyametaanalysisofrandomizedtrials AT budachwilfried nodifferenceinoverallsurvivalandnonbreastcancerdeathsafterpartialbreastradiotherapycomparedtowholebreastradiotherapyametaanalysisofrandomizedtrials AT corradinistefanie nodifferenceinoverallsurvivalandnonbreastcancerdeathsafterpartialbreastradiotherapycomparedtowholebreastradiotherapyametaanalysisofrandomizedtrials AT krugdavid nodifferenceinoverallsurvivalandnonbreastcancerdeathsafterpartialbreastradiotherapycomparedtowholebreastradiotherapyametaanalysisofrandomizedtrials AT tamaskovicsbalint nodifferenceinoverallsurvivalandnonbreastcancerdeathsafterpartialbreastradiotherapycomparedtowholebreastradiotherapyametaanalysisofrandomizedtrials AT bolkeedwin nodifferenceinoverallsurvivalandnonbreastcancerdeathsafterpartialbreastradiotherapycomparedtowholebreastradiotherapyametaanalysisofrandomizedtrials AT djiepmonjanangfreddyjoel nodifferenceinoverallsurvivalandnonbreastcancerdeathsafterpartialbreastradiotherapycomparedtowholebreastradiotherapyametaanalysisofrandomizedtrials AT simiantonakisioannis nodifferenceinoverallsurvivalandnonbreastcancerdeathsafterpartialbreastradiotherapycomparedtowholebreastradiotherapyametaanalysisofrandomizedtrials AT kammerskai nodifferenceinoverallsurvivalandnonbreastcancerdeathsafterpartialbreastradiotherapycomparedtowholebreastradiotherapyametaanalysisofrandomizedtrials AT matuschekchristiane nodifferenceinoverallsurvivalandnonbreastcancerdeathsafterpartialbreastradiotherapycomparedtowholebreastradiotherapyametaanalysisofrandomizedtrials |